Back to Trades
Katkin Keith
DirectorCIK: 0001314596
Katkin Keith, Director, has filed 2 insider trading reports covering 2 companies. Total disclosed trading volume is $218.4K. Sales ($128.2K) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves Emergent BioSolutions Inc. (EBS). All transactions sourced from SEC Form 4 filings.
Total Volume
$218.4K
Purchases
$0
Sales
$128.2K
Companies
2
Trading History (2 filings)
Sell
$128.2K
1 sale1 grant
Other
$0